$MOH

Molina outlines 2027 premium of at least $45B while EPS building blocks sum to more than $9.50 (NYSE:MOH)

Molina Healthcare (MOH) reported Q3 2026 adjusted EPS of $0.89 on $10.5B premium revenue. CEO Joseph noted a 92.9% medical cost ratio, indicating solid performance in a challenging environment. The company outlined 2027 premiums of at least $45B and EPS building blocks summing to over $9.50.

Original reporting
Published Oct 22, 2026, 8:59 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 9:03 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$MOH
Neutral
high confidence
Mentioned
$MOH
Relevance
8/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$MOHNeutralHigh
01

Why it matters

The earnings release provides fresh data on profitability and revenue, offering traders a basis for short‑term positioning.

02

Market read

First report of Q3 earnings; material numbers for a large-cap insurer, relevant for immediate trading decisions.

03

What to watch

Potential upcoming regulatory changes or cost-containment initiatives could offset revenue concerns.

Relevance 8/10Novelty 8/10Timing: after-hours release

Background

Molina Healthcare (MOH) is a U.S.-listed health insurance provider. The article summarizes its Q3 2026 earnings call.

Company-level read

Ticker impact

$MOHNeutralHigh confidence
Context

Molina Healthcare reported Q3 2026 adjusted EPS of $0.89 on $10.5B premium revenue, the first disclosure of these results.

Expected impact

likely modest pressure as investors weigh revenue growth against high cost environment

Evidence & confidence

The numbers are fresh and material; no guidance was provided, so traders may adjust positions based on the surprise EPS figure.

Market effects

Healthcare insurers may see similar pressure on margins amid rising medical costs.

U.S. health insurance sector could experience slight volatility.

Limited to U.S. markets; no broader macro impact.

Counterpoint

If premium revenue growth is stronger than implied, the stock could rally on the back of earnings beat.

Key entities

  • Molina Healthcare

    U.S. health insurer reporting Q3 2026 results.

Related articles

$MOHHighAI 8/10

Molina Healthcare (MOH) Q3 2026 Earnings Call Transcript

Molina Healthcare (MOH) reported Q3 2026 adjusted EPS of $0.89B on $10.5B premium revenue, with a 92.9% MCR. Full-year 2026 guidance remains $42B in premium revenue and at least $5.25 EPS. 2027 premium revenue is expected to be at least $45B, with known rate increases averaging 6% and medical cost trend projected at 5.5%-6%. The company reaffirmed its Medicaid and Medicare strategies, including exiting the MAPD business and reducing Marketplace footprint.

$MOHHighAI 8/10

Molina: Q3 Earnings Snapshot

Molina Healthcare (MOH) reported Q3 net income of $38M, or 73 cents per share, beating analyst estimates of 72 cents. Revenue was $11.08B, exceeding expectations of $10.93B. The company forecasts full-year earnings of $5.25 per share and revenue of $42B.

$MOHHighAI 8/10

Molina Healthcare’s (NYSE:MOH) Q3 2026 sales top estimates

Molina Healthcare (MOH) reported Q3 2026 revenue of $11.08B, down 3.4% YoY but exceeding estimates by 2%. Adjusted operating margin was 1.2%, and EPS was $0.89, down from last year but beating estimates. Analysts project 9% revenue growth and 311% EPS growth over the next 12 months. The stock fell 4.1% post-results.

$MOHHighAI 8/10

Molina Healthcare falls 4% on challenging environment, despite beating third quarter estimates

Molina Healthcare (NYSE:MOH) reported Q3 earnings of $0.89 per share, beating estimates by $0.10, with revenue at $11.08B, down 4% YoY. Shares fell 4.6% due to margin pressures and a challenging environment. The company reaffirmed its 2026 guidance of at least $5.25 per share. Membership and premium revenue declined due to lower Medicaid and Marketplace enrollment.